verapamil has been researched along with pentoxifylline in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Büyükpamukçu, N; Hiçsönmez, A; Oguzkurt, P; Okur, DH; Tanyel, FC | 1 |
| Czygier, M; Laudański, P; Szamatowicz, J | 1 |
| Dommerich, S; Graumüller, S; Hoff, M; Ostwald, J | 1 |
| Obruśnik, A; Pekala, E; Szymura-Oleksiak, J; Wyska, E | 1 |
| Bulaeva, SV; Chuchkanov, FA; Maimistova, AA; Muravyov, AV; Yakusevich, VV; Zaitsev, LG | 1 |
| Horvath, B; Kesmarky, G; Toth, K; Vekasi, J | 1 |
| Wyska, E | 2 |
| Levine, LA | 1 |
| Nikiteas, N; Perrea, D; Tsigris, C; Yiannakopoulou, E | 1 |
| Hellstrom, WJ; Mitchell, GC; Sangkum, P; Tan, RB | 1 |
| Alizadeh, M; Fallah, MR; Karimi, F | 1 |
| Gallo, L; Sarnacchiaro, P | 1 |
3 review(s) available for verapamil and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacological modulation of oxidative stress response in minimally invasive surgery: systematic review.
Topics: Acetylcysteine; Animals; Antioxidants; Biomarkers; Erythromycin; Humans; Laparoscopy; Melatonin; Mesna; Oxidative Stress; Pentoxifylline; Pneumoperitoneum, Artificial; Rabbits; Rats; Verapamil; Zinc Compounds | 2012 |
Update on medical management of Peyronie's disease.
Topics: 4-Aminobenzoic Acid; Administration, Topical; Adrenal Cortex Hormones; Disease Management; High-Energy Shock Waves; Humans; Interferon alpha-2; Interferon-alpha; Iontophoresis; Male; Penile Induration; Pentoxifylline; Radiotherapy; Recombinant Proteins; Stem Cell Transplantation; Traction; Ubiquinone; Vasodilator Agents; Verapamil; Vitamin E; Vitamins | 2014 |
1 trial(s) available for verapamil and pentoxifylline
| Article | Year |
|---|---|
Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Iran; Male; Middle Aged; Pain; Penile Induration; Pentoxifylline; Vasodilator Agents; Verapamil | 2014 |
17 other study(ies) available for verapamil and pentoxifylline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effects of vasodilatation and chemical sympathectomy on spermatogenesis after unilateral testicular torsion: a flow cytometric DNA analysis.
Topics: Animals; Dihydroxyphenylalanine; DNA; Flow Cytometry; Haploidy; Male; Pentoxifylline; Rats; Spermatic Cord Torsion; Spermatogenesis; Sympathectomy, Chemical; Testicular Diseases; Vasodilation; Vasodilator Agents; Verapamil | 1998 |
[Pentoxifylline and verapamil influence on the phagocytosis of peritoneal macrophages from women with endometriosis].
Topics: Adult; Calcium Channel Blockers; Endometriosis; Female; Humans; Macrophages, Peritoneal; Pentoxifylline; Phagocytosis; Phosphodiesterase Inhibitors; Verapamil | 2000 |
[Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Androstadienes; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Beclomethasone; Calcium Channel Blockers; Cells, Cultured; Culture Media; Diclofenac; Fibroblasts; Fluticasone; Glucocorticoids; Hematologic Agents; Humans; In Vitro Techniques; Mesalamine; Methylprednisolone; Mometasone Furoate; Muscarinic Agonists; Nasal Polyps; Pentoxifylline; Pilocarpine; Piroxicam; Prednisolone; Pregnadienediols; Time Factors; Timolol; Verapamil | 2003 |
Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Area Under Curve; Biological Transport; Hematologic Agents; Injections, Intravenous; Intestinal Absorption; Ketoconazole; Male; Mice; Models, Biological; Pentoxifylline; Verapamil | 2007 |
Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: in vitro study.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2007 |
In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model.
Topics: Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Free Radical Scavengers; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2008 |
Pretreatment with R(+)-verapamil significantly reduces mortality and cytokine expression in murine model of septic shock.
Topics: Animals; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytokines; Drug Synergism; Lipopolysaccharides; Liver; Lung; Male; Mice; Pentoxifylline; Prednisolone; Shock, Septic; Verapamil | 2009 |
Pharmacokinetic interaction between verapamil and methylxanthine derivatives in mice.
Topics: Adjuvants, Immunologic; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Male; Mice; Mice, Knockout; Pentoxifylline; Tissue Distribution; Vasodilator Agents; Verapamil | 2010 |
Current approach to the man with acute phase Peyronie's disease--case presentation and discussion.
Topics: Adult; Arginine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Injections, Intralesional; Interferons; Male; Papaverine; Penile Induration; Pentoxifylline; Phosphodiesterase Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Traction; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilator Agents; Verapamil | 2011 |
Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
Topics: Acute Disease; Administration, Oral; Arginine; Clinical Protocols; Combined Modality Therapy; Drug Administration Schedule; Humans; Injections, Intralesional; Male; Middle Aged; Organ Size; Patient Compliance; Penile Erection; Penile Induration; Penis; Pentoxifylline; Phosphodiesterase Inhibitors; Retrospective Studies; Traction; Vasodilator Agents; Verapamil | 2019 |